Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td class="align_left">ABCC3, ACTL6B, ANXA1, ANXA2, ATP1A3, C1R, CCK, CCL2, CD14, CD163, CD44, CHGA, CHGB, CHI3L1, CHI3L2, COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, COL6A2, CP, CPLX1, CPLX2, CXXC11, DLL3, EMP3, FAM163 B, FCGBP, FCGR2B, FCGR3A, GBP2, GDAP1L1, GPNMB, GRIN1, HLA-DRA, HLA-DRB1, IFI30, IGFBP2, INA, JPH3, KCNIP2, LTF, MMP9, MS4A6A, NNMT, NSG2, PDPN, PLA2G2A, S100A4, S100A8, S100A9, SCG3, SERPINA1, SERPINA3, SERPINE1, SEZ6L, SHD, SLC11A1, SLC16A3, SMOC1, SNAP25, SNCB, SOCS3, SPOCD1, SPP1, TGF-<i>β</i>1, TNFRSF12A, TREM1, TTC9B</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>List of genes significantly associated with survival in glioma.</div>

Journal of Oncology

tab3

Table 3

Table 3: Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA 